947 Participants Needed

Teleneonatology for Newborn Illness

Recruiting at 35 trial locations
JF
BM
Overseen ByBart M Demaerschalk, MD, MSc
Age: Any Age
Sex: Any
Trial Phase: Academic
Sponsor: Mayo Clinic
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

Trial Summary

What is the purpose of this trial?

The purpose of this study is to evaluate the impact of real-time audio-video telemedicine consults with a neonatologist (termed teleneonatology) on the early health outcomes of at-risk neonates delivered in community hospitals.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What data supports the effectiveness of the treatment Teleneonatology for newborn illness?

Research suggests that teleneonatology, which involves remote consultations by neonatologists, can improve the quality of care for high-risk newborns in community hospitals. Studies indicate that it may enhance newborn resuscitation and improve stability scores, which predict the risk of mortality for transported neonates.12345

Is teleneonatology safe for newborns?

The available research does not specifically address the safety of teleneonatology, but it is used to manage critically ill newborns and improve care quality, suggesting it is generally considered safe in practice.12456

How is the treatment Teleneonatology different from other treatments for newborn illness?

Teleneonatology is unique because it uses telemedicine to provide remote care and expert consultation for newborns, especially in community hospitals, which can improve the quality of care and outcomes for high-risk newborns. This approach allows specialists to assist local care teams in real-time, which is not typically possible with traditional in-person treatments.12467

Research Team

JF

Jennifer Fang, MD

Principal Investigator

Mayo Clinic

BM

Bart Demaerschalk, MD

Principal Investigator

Mayo Clinic

MG

Meegan G Van Straaten, MSPH

Principal Investigator

Mayo Clinic

Eligibility Criteria

The TELENEO Trial is for newborns needing advanced resuscitation in community hospitals and the physicians attending these births. Eligible babies may have received ventilation or chest compressions, or be born preterm (<32 weeks). Physicians with neonatal-perinatal specialty are excluded, as are babies planned for comfort care, born outside a birthing center, or with severe congenital anomalies.

Inclusion Criteria

I have an alternative airway in place for positive pressure ventilation.
This group consists of outborn neonates at risk for complications.
You are a physician who attends baby resuscitations at an authorized local hospital location.
See 7 more

Exclusion Criteria

I needed intensive care or surgery within the first two weeks of my life due to a severe birth defect.
Birth outside of the hospital birthing center.
I have completed a fellowship in neonatal-perinatal medicine.
See 5 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Real-time audio-video telemedicine consults with a neonatologist for at-risk neonates in community hospitals

First 7 days of life
Continuous monitoring via telemedicine

Follow-up

Participants are monitored for early mortality and morbidity outcomes

7 days

Treatment Details

Interventions

  • Teleneonatology
Trial Overview This study tests teleneonatologyโ€”real-time video calls with neonatologists during critical newborn resuscitations. It aims to improve early health outcomes of at-risk neonates by providing expert guidance to doctors in community hospitals when they face complex cases.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Teleneonatology groupExperimental Treatment1 Intervention
Study eligible neonates cared for by the community hospital team with telemedicine consultation by a neonatologist from the regional neonatal intensive care unit (NICU).
Group II: Control groupActive Control1 Intervention
Study eligible neonates cared for by the community hospital team per the site's usual practice of care.

Teleneonatology is already approved in United States, Canada, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Teleneonatology for:
  • Advanced neonatal resuscitations
  • High-risk neonatal care
๐Ÿ‡จ๐Ÿ‡ฆ
Approved in Canada as Neonatal Telemedicine for:
  • Neonatal intensive care
  • Remote neonatal consultations
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Teleneonatology for:
  • Neonatal emergency care
  • Telemedicine for newborns

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

Trials
2,103
Recruited
2,760,000+

Findings from Research

Teleneonatology is advancing rapidly, offering innovative telemedicine solutions for various aspects of neonatal care, which can improve access to specialized medical services for newborns.
The chapter provides a comprehensive framework for developing, implementing, and evaluating teleneonatology programs, while also addressing barriers to implementation and suggesting potential solutions.
Development and implementation of a teleneonatology program: Opportunities and challenges.Jagarapu, J., Savani, RC.[2021]
The pilot study demonstrated that a multicenter teleneonatology trial is feasible, achieving a high mean composite feasibility score of 4.6 out of 5 across 20 months, indicating strong site retention and timely data management.
With a very low eligibility error rate of 0.2% and 90% of screening logs completed on time, the pilot suggests that teleneonatology could effectively support at-risk neonates in community hospitals, paving the way for a larger clinical effectiveness trial.
Evaluating the feasibility of a multicenter teleneonatology clinical effectiveness trial.Fang, JL., Umoren, RA., Whyte, H., et al.[2023]
A survey of 111 participants from 6 community hospitals showed that 94.6% agreed that teleneonatology is necessary, and 96.2% found teleneonatology consults helpful, indicating strong support for this service among local care providers.
Barriers and facilitators to implementing teleneonatology were identified, including the importance of education, communication, and streamlined workflows, which are crucial for successful integration into community healthcare settings.
A Mixed-Methods Study on the Barriers and Facilitators of Telemedicine for Newborn Resuscitation.Fang, JL., Asiedu, GB., Harris, AM., et al.[2022]

References

Development and implementation of a teleneonatology program: Opportunities and challenges. [2021]
Evaluating the feasibility of a multicenter teleneonatology clinical effectiveness trial. [2023]
A Mixed-Methods Study on the Barriers and Facilitators of Telemedicine for Newborn Resuscitation. [2022]
The impact of telemedicine on the quality of newborn resuscitation: A retrospective study. [2022]
The impact of teleneonatology on the Transport Risk Index of Physiologic Stability score for outborn neonates: A prospective, observational study. [2023]
Provider Perspectives on the Acceptability, Appropriateness, and Feasibility of Teleneonatology. [2023]
Telemedicine in neonatal medicine and resuscitation. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity